statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reviva Pharmaceuticals Holdings, Inc. - RVPH SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reviva Pharmaceuticals Holdings, Inc. - RVPH

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH...

RVPH LOSS ALERT: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation RVPH

This price move could indicate a change in the trend, and may be a sell signal for investors...

Reviva Pharmaceuticals Holdings (RVPH, $3.79) price exceeded its 50-day Moving Average on March 28, 2024

CUPERTINO, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ( Reviva or the Company ), a late-stage pharmaceutical company developing therapies that...

Reviva to Present RECOVER Phase 3 Clinical Trial Data for Brilaroxazine in Schizophrenia at the SIRS 2024 Annual Meeting

CUPERTINO, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ( Reviva or the Company ), a late-stage pharmaceutical company developing therapies that...

Reviva to Present RECOVER Phase 3 Clinical Trial Data for Brilaroxazine in Schizophrenia at the ASCPT 2024 Annual Meeting

CUPERTINO, Calif., March 11, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ( Reviva or the Company ), a late-stage pharmaceutical company developing therapies that...

Reviva to Present at the UBS Virtual CNS Day

CUPERTINO, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ( Reviva or the Company ), a late-stage pharmaceutical company developing therapies that...

Reviva to Present at the 36th Annual ROTH Conference

Reviva Pharmaceuticals Holdings (RVPH, $4.01) price exceeded its 50-day Moving Average on February 27, 2024

Reviva Pharmaceuticals Holdings (RVPH, $4.25) price exceeded its 50-day Moving Average on February 21, 2024

CUPERTINO, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ( Reviva or the Company ), a late-stage pharmaceutical company developing therapies that...

Reviva Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. It uses chemical genomics driven technology platform and proprietary chemistry to develop new medicines. It focuses on the RP5063 (Brilaroxazine) and RP1208 pipelines. The company was founded by Laxminarayan Bhat on December 11, 2020 and is headquartered in Cupertino, CA.

Volume	89,051.00
52-Wk High	$9.25
52-Wk Low	$2.67

Period	Estimated	Reported	Surprise	Result
Q1'24	-$0.38	--	--	N/A
Q4'23	-$0.38	-$0.36	4.00%	BEAT
Q3'23	-$0.36	-$0.44	-23.36%	MISSED
Q2'23	-$0.28	-$0.55	-99.28%	MISSED
Q1'23	-$0.30	-$0.30	--	EXPECTED

RVPH Reviva Pharmaceuticals Holdings Inc.

About

Feed

News

Sentiment

Earnings

Fundamentals